Spin-out/Start-up companies
The University actively supports entrepreneurs and academic staff in the creation of new ventures to lead the exploitation of research generated opportunities. This support ranges from licensing IP to start-ups to directly supporting the planning/ formation of a spin-out venture. Since 2006, the University has had a partnership with leading early-stage investor - IP Group plc who provide expertise in company creation and access to investment.
More information about our approach to Intellectual Property and Commercialisation can be found in our policies.
If you are interested in finding out more about our pipeline of spinout companies and how you could get involved please contact Melville Anderson, Head of IP & Commercialisation.
University of Glasgow - Venture Portfolio
Intense uses propietary Quantum Well Intermixing (QWI) technology and manufacturing processes to create diode laser products with unrivalled levels of power, brightness and reliability for range of markets.
VIRTTU Biologics uses pre-clinical and clinical development of a proprietary oncolytic virus therapy for the treatment of a range of cancers. The company is in Phase I / II clinical trials with product.
Dimensional Imaging develops 3D and 4D surface imaging software and services for applications in life sciences and entertainment industires.
MD Biosciences is a pre-clinical and clinical contract research organisation (CRO) providing in vitro and in vivo nonclinical efficacy studies as well as a clinical biomarker and general chemistry analysis.
Cara Therapeutics is involved in pre-clinical and clinical development of novel therapeutics to treat conditions associated with pain and inflammation. The company is in Phase IIB clinical trials with its lead product.
Created by Cancer Research Technologies, Senectus Therapeutics is a drug discovery and development venture focused on identifying novel therapeutics that target cellular senescence.
Kelvin Nanotechnology provides nanofabriction design and manufacturing services specialising in high resolution, electron beam lithography.
XstalBio is developing a properiety drug delivery technology for use with vaccines and biopharmaceuticals.
Gold Standard Simulations Ltd is developing and licensing semi-conductor design softward to companies engaged in sub 22nm device design and manufacture. The company also provide a range of services.
Mode Diagnostics (MODE DX) is developing a consumer orientated health monitoring platform for Over-the-Counter (OTC) retail pharmacy market.
Brainwave is a contract research organisation delivering CNS testing services using transgenic fruit flies (Drosophila) to drug discovery companies.
Anacail develops automated ozone generation equipment for surface decontamination applications in industries such as food, medical and consumer goods.
Acquired by Airwave:
Acquired by Avacta:
Acquired by Gemfire: